Nu-Med Plus (NUMD) EBITDA (2012 - 2025)
Nu-Med Plus' (NUMD) quarterly EBITDA came in at -$9761.0 in Q4 2025, down 5.02% year-on-year from -$10277.4 in Q4 2024, and up 3.12% quarter-over-quarter from -$10075.0 in Q3 2025.
Nu-Med Plus (NUMD) EBITDA (2012 - 2025) Analysis & Trends
Nu-Med Plus has disclosed EBITDA across 14 years of filings, most recently posting -$9761.0 for Q4 2025.
- EBITDA for Q4 2025 came in at -$9761.0, down 5.02% year-over-year; the trailing twelve-month figure through Dec 2025 was -$48955.0 (up 22.7% YoY), and the FY2025 annual result was -$48955.0, up 22.7% from the prior year.
- EBITDA came in at -$9761.0 for Q4 2025 at Nu-Med Plus, up from -$10075.0 in the prior quarter.
- In the past five years, EBITDA ranged from a high of -$6394.0 in Q4 2022 to a low of -$354099.0 in Q1 2021.
- The 5-year median for EBITDA is -$21826.0 (2023), against an average of -$62152.2.
- Across the five-year window, EBITDA surged 94.17% in 2022 and slumped 765.44% in 2023, its largest moves.
- Nu-Med Plus' EBITDA stood at -$109691.0 in 2021, then surged by 94.17% to -$6394.0 in 2022, then plunged by 765.44% to -$55336.0 in 2023, then soared by 83.2% to -$9294.0 in 2024, then retreated by 5.02% to -$9761.0 in 2025.
- The last three EBITDA figures came in at -$9761.0 (Q4 2025), -$10075.0 (Q3 2025), and -$10419.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.35 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 936.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.46 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.10 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 477.60 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 663.81 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 255.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 515.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 316.80 Mn |
| 10 | Nu-Med Plus | - | - | - | -9,761.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -9,761.00 |
| Sep 30, 2025 | -10,075.00 |
| Jun 30, 2025 | -10,419.00 |
| Mar 31, 2025 | -18,700.00 |
| Dec 31, 2024 | -9,294.00 |
| Sep 30, 2024 | -17,417.00 |
| Jun 30, 2024 | -16,040.00 |
| Mar 31, 2024 | -20,579.00 |
| Dec 31, 2023 | -55,336.00 |
| Sep 30, 2023 | -15,146.00 |
| Jun 30, 2023 | -23,073.00 |
| Mar 31, 2023 | -26,971.00 |
| Dec 31, 2022 | -6,394.00 |
| Sep 30, 2022 | -58,050.00 |
| Jun 30, 2022 | -58,070.00 |
| Mar 31, 2022 | -57,638.00 |
| Dec 31, 2021 | -109,691.00 |
| Sep 30, 2021 | -115,717.00 |
| Jun 30, 2021 | -250,573.00 |
| Mar 31, 2021 | -354,099.00 |